Releases › HCPCS Level II July 2024

HCPCS Level II July 2024

Effective 2024-07-01 to 2024-09-30. 8,416 codes in the release.

67added
32revised
11removed

Codes added 67

CodeDescription
A9506 Graphite crucible for preparation of technetium tc 99m-labeled carbon aerosol, one crucible
C1605 Pacemaker, leadless, dual chamber (right atrial and right ventricular implantable components), rate-responsive, including all necessary components for implantation
C1606 Adapter, single-use (i.e. disposable), for attaching ultrasound system to upper gastrointestinal endoscope
C9901 Endoscopic defect closure within the entire gastrointestinal tract, including upper endoscopy (including diagnostic, if performed) or colonoscopy (including diagnostic, if performed), with all system and tissue anchoring components
G0519 Management of new patient-caregiver dyad with dementia, low complexity, for use in cmmi model
G0520 Management of new patient-caregiver dyad with dementia, moderate complexity, for use in cmmi model
G0521 Management of new patient-caregiver dyad with dementia, high complexity, for use in cmmi model
G0522 Management of a new patient with dementia, low complexity, for use in cmmi model
G0523 Management of a new patient with dementia, moderate to high complexity, for use in cmmi model
G0524 Management of established patient-caregiver dyad with dementia, low complexity, for use in cmmi model
G0525 Management of established patient-caregiver dyad with dementia, moderate complexity, for use in cmmi model
G0526 Management of established patient-caregiver dyad with dementia, high complexity, for use in cmmi model
G0527 Management of established patient with dementia, low complexity, for use in cmmi model
G0528 Management of established patient with dementia, moderate to high complexity, for use in cmmi model
G0529 In-home respite care, 4-hour unit, for use in cmmi model
G0530 Adult day center, 8-hour unit, for use in cmmi model
G0531 Facility-based respite, 24-hour unit, for use in cmmi model
G9037 Interprofessional telephone/internet/electronic health record clinical question/request for specialty recommendations by a treating/requesting physician or other qualified health care professional for the care of the patient (i.e. not for professional education or scheduling) and may include subsequent follow up on the specialist's recommendations; 30 minutes
G9038 Co-management services with the following elements: new diagnosis or acute exacerbation and stabilization of existing condition; condition which may benefit from joint care planning; condition for which specialist is taking a co-management role; condition expected to last at least 3 months; comprehensive care plan established, implemented, revised or monitored in partnership with co-managing clinicians; ongoing communication and care coordination between co-managing clinicians furnishing care
J0211 Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)
J0687 Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg
J0872 Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
J0911 Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous catheter lock for adult patients receiving chronic hemodialysis)
J1597 Injection, glycopyrrolate (glyrx-pf), 0.1 mg
J1598 Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg
J1748 Injection, infliximab-dyyb (zymfentra), 10 mg
J2183 Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg
J2246 Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg
J2267 Injection, mirikizumab-mrkz, 1 mg
J2373 Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms
J2468 Injection, palonosetron hydrochloride (avyxa), not therapeutically equivalent to j2469, 25 micrograms
J2470 Injection, pantoprazole sodium, 40 mg
J2471 Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg
J3247 Injection, secukinumab, intravenous, 1 mg
J3263 Injection, toripalimab-tpzi, 1 mg
J3393 Injection, betibeglogene autotemcel, per treatment
J3394 Injection, lovotibeglogene autotemcel, per treatment
J7171 Injection, adamts13, recombinant-krhn, 10 iu
J7355 Injection, travoprost, intracameral implant, 1 microgram
J8611 Methotrexate (jylamvo), oral, 2.5 mg
J8612 Methotrexate (xatmep), oral, 2.5 mg
J9361 Injection, efbemalenograstim alfa-vuxw, 0.5 mg
Q4311 Acesso, per square centimeter
Q4312 Acesso ac, per square centimeter
Q4313 Dermabind fm, per square centimeter
Q4314 Reeva ft, per square cenitmeter
Q4315 Regenelink amniotic membrane allograft, per square centimeter
Q4316 Amchoplast, per square centimeter
Q4317 Vitograft, per square centimeter
Q4318 E-graft, per square centimeter
Q4319 Sanograft, per square centimeter
Q4320 Pellograft, per square centimeter
Q4321 Renograft, per square centimeter
Q4322 Caregraft, per square centimeter
Q4323 Alloply, per square centimeter
Q4324 Amniotx, per square centimeter
Q4325 Acapatch, per square centimeter
Q4326 Woundplus, per square centimeter
Q4327 Duoamnion, per square centimeter
Q4328 Most, per square centimeter
Q4329 Singlay, per square centimeter
Q4330 Total, per square centimeter
Q4331 Axolotl graft, per square centimeter
Q4332 Axolotl dualgraft, per square centimeter
Q4333 Ardeograft, per square centimeter
Q5137 Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg
Q5138 Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mg

Descriptions revised 32

CodeWas, and is now
J0134 Injection, acetaminophen (fresenius kabi) not therapeutically equivalent to j0131, 10 mg Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg
J0136 Injection, acetaminophen (b braun) not therapeutically equivalent to j0131, 10 mg Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg
J0137 Injection, acetaminophen (hikma) not therapeutically equivalent to j0131, 10 mg Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg
J0173 Injection, epinephrine (belcher) not therapeutically equivalent to j0171, 0.1 mg Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg
J0401 Injection, aripiprazole, extended release, 1 mg Injection, aripiprazole (abilify maintena), 1 mg
J0651 Injection, levothyroxine sodium (fresenius kabi) not therapeutically equivalent to j0650, 10 mcg Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg
J0652 Injection, levothyroxine sodium (hikma) not therapeutically equivalent to j0650, 10 mcg Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg
J0873 Injection, daptomycin (xellia) not therapeutically equivalent to j0878, 1 mg Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg
J0893 Injection, decitabine (sun pharma) not therapeutically equivalent to j0894, 1 mg Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
J1574 Injection, ganciclovir sodium (exela) not therapeutically equivalent to j1570, 500 mg Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg
J1806 Injection, esmolol hydrochloride (wg critical care) not therapeutically equivalent to j1805, 10 mg Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg
J1921 Injection, labetalol hydrochloride (hikma) not therapeutically equivalent to j1920, 5 mg Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg
J2021 Injection, linezolid (hospira) not therapeutically equivalent to j2020, 200 mg Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg
J2184 Injection, meropenem (b. braun) not therapeutically equivalent to j2185, 100 mg Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg
J2251 Injection, midazolam hydrochloride (wg critical care) not therapeutically equivalent to j2250, per 1 mg Injection, midazolam hydrochloride (wg critical care), not therapeutically equivalent to j2250, per 1 mg
J2272 Injection, morphine sulfate (fresenius kabi) not therapeutically equivalent to j2270, up to 10 mg Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg
J2281 Injection, moxifloxacin (fresenius kabi) not therapeutically equivalent to j2280, 100 mg Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg
J2599 Injection, vasopressin (american regent) not therapeutically equivalent to j2598, 1 unit Injection, vasopressin (american regent), not therapeutically equivalent to j2598, 1 unit
J2806 Injection, sincalide (maia) not therapeutically equivalent to j2805, 5 micrograms Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms
J3244 Injection, tigecycline (accord) not therapeutically equivalent to j3243, 1 mg Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg
J3371 Injection, vancomycin hcl (mylan) not therapeutically equivalent to j3370, 500 mg Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg
J3372 Injection, vancomycin hcl (xellia) not therapeutically equivalent to j3370, 500 mg Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg
J9046 Injection, bortezomib, (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg
J9172 Injection, docetaxel (ingenus) not therapeutically equivalent to j9171, 1 mg Injection, docetaxel (ingenus), not therapeutically equivalent to j9171, 1 mg
J9258 Injection, paclitaxel protein-bound particles (teva) not therapeutically equivalent to j9264, 1 mg Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg
J9259 Injection, paclitaxel protein-bound particles (american regent) not therapeutically equivalent to j9264, 1 mg Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mg
J9294 Injection, pemetrexed (hospira) not therapeutically equivalent to j9305, 10 mg Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg
J9296 Injection, pemetrexed (accord) not therapeutically equivalent to j9305, 10 mg Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg
J9314 Injection, pemetrexed (teva) not therapeutically equivalent to j9305, 10 mg Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg
J9322 Injection, pemetrexed (bluepoint) not therapeutically equivalent to j9305, 10 mg Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg
J9393 Injection, fulvestrant (teva) not therapeutically equivalent to j9395, 25 mg Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg
Q2055 Idecabtagene vicleucel, up to 460 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Terminated 11

CodeDescription
C9113 Injection, pantoprazole sodium, per vial
C9166 Injection, secukinumab, intravenous, 1 mg
C9167 Injection, adamts13, recombinant-krhn, 10 iu
C9168 Injection, mirikizumab-mrkz, 1 mg
C9787 Gastric electrophysiology mapping with simultaneous patient symptom profiling
C9790 Histotripsy (ie, non-thermal ablation via acoustic energy delivery) of malignant renal tissue, including image guidance
J2780 Injection, ranitidine hydrochloride, 25 mg
J9371 Injection, vincristine sulfate liposome, 1 mg
Q4210 Axolotl graft or axolotl dualgraft, per square centimeter
Q4277 Woundplus membrane or e-graft, per square centimeter
S0164 Injection, pantoprazole sodium, 40 mg